Absci is headquartered in Vancouver, Washington.
Absci disclosed revenue of 4M USD for 2024 and 6M USD for 2023.
Absci has 156 employees.
Absci is a life science company.
Absci was founded in 2011.
18105 SE Mill Plain Boulevard,
Vancouver, Washington
98683
United States,
(360) 949-1041
www.absci.com
Absci is a synthetic biology company enabling drug discovery and biomanufacturing of next-generation biotherapeutics. Absci patented SoluPro E. coli expression system and Protein Printing platform enable simultaneous creation of novel biotherapeutic drugs and the cell lines to manufacture them in a single efficient process. Absci was founded in 2011 and is based in Vancouver, Washington.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.4/yr) | # | - | 2 | - | - | - | - | 2 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 2 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
